Inhibition of histone deacetylase safely suppresses tumor growth in ovarian cancer-bearing mice Nov. 2, 2001
CEP-5214, a new VEGF receptor tyrosine kinase inhibitor, effective in prostate tumor models Nov. 2, 2001
Novel antiangiogenic agent targeting alpha5beta1 integrin presented at AACR-NCI-EORTC meeting Nov. 2, 2001
Canadian team designs bifunctional nitrosourea with signal transduction-inhibitory effects Nov. 2, 2001
New compound discovered as a result of continued focus on topoisomerase inhibitors at Xenova Nov. 2, 2001